Invivyd Inc

IVVDNASDAQ · USD
1.02USD0.00 (+35.05%)
325

Invivyd Inc (IVVD) Covered Calls

As of September 21, 2026, IVVD has 8 covered call opportunities in the coming three months. Return ranges from 44.7 to 235.5% until expiration. Annualized return ranges from 129.3 to 1,355.0%. The nearest expiration is October 16, 2026. Maximum potential profit is $179.

Read more

Running IVVD covered calls helps you generate consistent income from Invivyd Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Invivyd Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best IVVD covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if IVVD stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling IVVD covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Invivyd Inc covered call is worth writing.

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses.

The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Income-focused investors, long-term IVVD holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling IVVD covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Invivyd Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile97.22% Elevated
  • Market cap (M$)301
  • 52 weeks high-66.78%
  • 52 weeks low92.45%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$10.00
    880.39% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-05
  • P/E
  • Future P/E
  • EPS (ttm)-0.37
  • EPS growth next 5 years19.51%

As of September 21, 2026

2026-10-16281.5097.370.050.1079.00103.951355.03-6.58+0.304,4980.05
2026-12-18912.50228.950.050.10179.00235.53944.69-6.58+0.252,0890.05
2026-11-20631.5097.370.050.3079.00103.95602.23-6.58+0.4700.25
2026-10-16281.0031.580.100.2034.0044.74583.18-13.16+0.502,3340.10
2026-12-18911.5097.370.100.2584.00110.53443.32-13.16+0.474,1350.15
2026-12-18911.0031.580.150.4039.0051.32205.83-19.74+0.643,6010.25
2027-01-151191.0031.580.200.2544.0057.89177.58-26.32+0.599600.05
2027-03-191821.0031.580.250.4049.0064.47129.30-32.89+0.689550.15

As of September 21, 2026

Sell covered calls with the data behind you

Find the best IVVD covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial